DIRS.INFO top alerts submit data jurnalism about API
login
Top related persons:
— - 11 it's - 10 Eli Lilly - 8 Oppenheimer - 7 Morgan Stanley - 6 Goldman Sachs - 6 Jim Cramer - 5 Jim Cramer's - 5
Top related locs:
U.S Dover China biopharma Bristol Eaton Gilead New Jersey
Top related orgs:
Nvidia - 12 JPMorgan - 8 CNBC - 7 Bank of America - 7 Citi - 6 Dover - 5 UBS - 4 Therapeutics - 4

Search resuls for: "Biopharma"


25 mentions found


☆ Strong earnings from industrial AI play Dover prove the stock belongs in our portfolio
  + stars: | 2024-07-25 | by ( Jim Cramer | ) www.cnbc.com   time to read: +8 min
Dover's active portfolio management and commitment to capital returns sweeten the investment case. Tobin said the moves will boost Dover's clean-energy portfolio and decrease its exposure to more cyclical capital equipment businesses. I think that what's doing better than planned as the margin performance of the business has just been exemplary through the quarter," Tobin said. Guidance Dover now expects adjusted full-year earnings per share between $9.05 and $9.20, up from its previous range of $9.00 to $9.15. Jim waits 45 minutes after sending a trade alert before buying or selling a stock in his charitable trust's portfolio.
Persons: —, Ingersoll Rand, Jim Cramer, Richard Tobin, Tobin, Encouragingly, It's, Marshall Excelsior, Demaco —, we've, That's, it's, DOV YTD, Dover, biopharma —, Danaher, he's, Jim Cramer's, DOV, Jim, Rafael Henrique Organizations: LSEG, IDEX Corp, Dover, Environmental Solutions Group, Engineered Products, Management, Solutions, Sustainability Technologies, Sustainability Tech, Environmental Solutions, CNBC, Getty Locations: Dover, Veralto, Michigan, biopharma
☆ Alphabet earnings and 3 more things we're watching in the stock market next week
  + stars: | 2024-07-20 | by ( Zev Fima | ) www.cnbc.com   time to read: +12 min
But in general, this is the kind of development we've hoped to see ever since Starbucks' massive earnings miss April 30. We'll take the nearly 7% pop in shares Friday and hope it's only the beginning of recovery for the beaten-up stock. Fed's fave inflation measure : The personal spending and income report will be the most closely watched economic report next week. Earnings : As the second-quarter earnings season picks up pace, we'll hear from five Club holdings next week including Google parent Alphabet . Jim waits 45 minutes after sending a trade alert before buying or selling a stock in his charitable trust's portfolio.
Persons: Russell, Donald Trump, — Trump, Jim Cramer, Trump, Donald Trump's, Taiwan's TSMC, Joe Biden's, Biden, Biden's, he's, Elliott, we've, We'll, it's, we'll, Sartorius, Ford, Jim Farley, We're, Honeywell management's, —, Zions, BOK, Brown, BRO, Lockheed Martin, Philip Morris, Clark, Lamb, Edwards Lifesciences, DOV, Dr Pepper, CARR, Baker Hughes, Booz Allen Hamilton, Jim Cramer's, Jim Organizations: Federal Reserve, Nasdaq, Dow, Republican National Convention, GOP, Bloomberg Businessweek, Trump, Elliott Management, Starbucks, Street Journal, Technology, General Motors, Honeywell, Dover, Products Company, Verizon, Truist, SAP, Semiconductors, Crown Holdings, Cadence Design Systems, Medpace Holdings, AGNC Investment, Logitech International S.A, KKR Real Estate Finance Trust, Berkley Corp, Spotify Technology S.A, United Parcel Service, GE Aerospace, GE, Cola Company, Lockheed, Comcast, Polaris Industries, Philip Morris International, Company, HCA Healthcare, Moody's Corporation, Enphase Energy, Texas Instruments Incorporated, Chubb Corporation, Seagate Technology plc, Maine, Packaging Corporation of America, Weatherford International plc, Canadian National Railway Company, FTAI Aviation Ltd, Mattel, Vertiv Holdings Co, Lamb Weston Holdings, NextEra Energy, Tenet Healthcare, Fisher, GE Vernova, Boston Scientific Corporation, General Dynamics, Lennox International, Software Technologies, CME Group, Fortive Corporation, Co, Roper Technologies, Teck Resources Limited, Blackstone Mortgage Trust, Economico Mexicano S.A, Dominion Freight, Otis Worldwide Corporation, OTIS, Ford Motor Company, Grill, Business Machines, IBM, Viking Therapeutics, Las Vegas Sands Corp, Newmont, Whirlpool, Globe, WM, O'Reilly Automotive, Annaly Capital Management, Honeywell International, American Airlines Group, Hasbro, Southwest Airlines Co, New York Community Bancorp, RTX Corporation, AstraZeneca, Carrier Global Corporation, Integer Holdings Corporation, Valero Energy, Texas, Juniper Networks, Boston Beer Company, Physicians Realty Trust, Allison Transmission Holdings, Corp, Columbia Banking, Digital Realty Trust, Edison International, Myers Squibb, Charter Communications, 3M Company, Booz, Centene Corporation, AON, Barnes, Colgate, Palmolive, Jim Cramer's Charitable, CNBC, U.S Locations: U.S, Taiwan, FactSet, China, Dover, Cleveland, Alexandria, ZION, W.R, Freeport, Kimberly, Cal, Teck, Las, ORLY, New, Banc, Bristol, Milwaukee , Wisconsin
☆ Wall Street analysts love this recent IPO that's an AI play in the health-care sector
  + stars: | 2024-07-09 | by ( Lisa Kailai Han | ) www.cnbc.com   time to read: +2 min
Wall Street analysts are bullish on recently launched health-care technology stock Tempus AI . By combining a patient's molecular, clinical, and imaging data with its AI platform, Tempus delivers personalized therapy decisions," he wrote. Tempus AI debuted at the Nasdaq on June 14, closing at $40 after pricing its initial public offering at $37. Last month, investment management firm SoftBank announced it had invested about $200 million in Tempus AI before its Nasdaq listing. Since its debut, Tempus AI stock has slipped 10% from its IPO price.
Persons: Michael Ryskin, SoftBank, America's Ryskin, Ryskin, JPMorgan's Rachel Vatnsdal, William Blair, Morgan Stanley, Tejas Savant, TD Cowen, Dan Brennan Organizations: Bank of America, Tempus, Nasdaq, America's, Precision Oncology, Loop Capital Locations: Stifel, Needham
☆ Stocks making the biggest moves premarket: Paramount, SolarEdge, Morphic Holding and more
  + stars: | 2024-07-08 | by ( Hakyung Kim | ) www.cnbc.com   time to read: +2 min
Morphic Holding — Shares surged more than 75% on news that Eli Lilly will acquire the biopharma company in a $3.2 billion deal . The deal will give Eli Lilly access to Morphic's portfolio of treatments in development, such as those for ulcerative colitis and Crohn's disease. Eli Lilly shares inched up 0.2% on the news. SolarEdge — The energy company rose 5% after Bank of America upgraded shares to neutral from underperform, citing an attractive entry point for investors. Gilead — Shares of the biotech stock rose more than 2% after an upgrade to outperform from market perform at Raymond James.
Persons: Eli Lilly, SolarEdge, Guggenheim, ServiceNow, John DiFucci, Baird, Gilead —, Raymond James, Gilead, Sarah Min, Jesse Pound, Michelle Fox, Yun Li Organizations: Paramount, Skydance Media, Bank of America, PNC, UBS, KeyCorp, Columbia, —
☆ Here are Monday's biggest analyst calls: Nvidia, Apple, Meta, PNC, Domino's, Charles Schwab, Roblox, SolarEdge & more
  + stars: | 2024-07-08 | by ( Michael Bloom | ) www.cnbc.com   time to read: +7 min
Here are Monday's biggest calls on Wall Street: UBS reiterates Nvidia as buy UBS raised its price target on Nvidia to $150 per share from $120. Stifel upgrades Ecolab to buy from hold Stifel said it's bullish on shares of the food safety company. KBW upgrades Charles Schwab to outperform from market perform KBW said it's getting bullish on shares of Charles Schwab. Wells Fargo reiterates Meta as overweight Wells raised its price target on Meta to $625 per share from $593. Wells Fargo reiterates Roblox as overweight Wells raised its price target on the stock to $43 per share from $41 ahead of earnings on August 1.
Persons: Stifel, it's, Morgan Stanley, Charles Schwab, KBW, Guggenheim, ServiceNow, Wells, Riley, Emerson, Redburn, Wolfe, JPM, Raymond James, Gilead, Bumble, TD Cowen, Oppenheimer, Jefferies, Baird, Wedbush, RBLX Organizations: UBS, Nvidia, Taiwan Semiconductor, Meta, PNC, Bank of America, underperform Bank of America, Medicines, NSC, Apple, JPMorgan, Disney Locations: 2H24, Columbia, Norfolk, Asia
☆ Investors want proof AI will aid drug discovery. Evidence may come in the second half
  + stars: | 2024-07-06 | by ( Christina Cheddar Berk | In | ) www.cnbc.com   time to read: +10 min
Analysts who have been following companies on the cutting edge of using generative AI for drug discovery say it is still very early days. But these endorsements haven't lifted Recursion shares out of a slump. RXRX 1Y mountain Recursion shares over the past year. The drug company will be a beta user of Recursion's LOWE (Large Language Model-Orchestrated Workflow Engine) and the pair are also partnering on oncology research. SDGR 1Y mountain Schrodinger shares over the past year.
Persons: Scott Schoenhaus, Chris Gibson, Jensen Huang, Leerink, Mani Foroohar, Foroohar, Recursion's, KeyBanc's Schoenhaus, Needham, Gil Blum, it's, Recursion's LOWE, Blum, Eli Lilly, AbCellera, KeyBanc's, Schoenhaus, FactSet, Allison Bratzel, Piper Sandler, Goldman Sachs, Salveen Richter, Peter Lawson, Lawson, Japan's Takeda, Schrodinger, Leerink's Foroohar Organizations: Analysts, Capital, Nvidia, ARK Investment Management, REC, CCM, Union, Bayer, Therapeutics, Dynamo, RLY, Barclays, Japan's Locations: U.S, biopharma, Biohive
☆ This fund manager beating the market is betting AI stocks like Micron will outperform again in second half
  + stars: | 2024-07-03 | by ( Lisa Kailai Han | ) www.cnbc.com   time to read: +3 min
The second half of the year is underway, and investor Andrew Graham thinks technology stocks will continue to lead the market higher. Investors have debated whether technology stocks can sustain their lofty gains, or if the market rally is due to broaden. The investor likes semiconductor names such as Nvidia and Micron , which he said should benefit from the ongoing memory cycle. MU YTD mountain MU year to date Outside of tech, Graham favors industrials, which are adjacent to the AI theme. The portfolio manager also has positions in NextEra Energy , which he thinks is primed to capitalize on AI.
Persons: Andrew Graham, Graham, —, industrials, that's, Eli Lilly, Capital's Organizations: Nvidia, Investors, Jackson, Capital, CNBC, Micron, MU, Arista, Dell, Arm Holdings, Broadcom, NextEra Energy Locations: Eaton, Graham, U.S
☆ Stocks making the biggest moves premarket: Gilead Sciences, Sarepta Therapeutics, Nike and more
  + stars: | 2024-06-21 | by ( Lisa Kailai Han | ) www.cnbc.com   time to read: +2 min
The decline comes after the AI chipmaker on Tuesday briefly topped Microsoft as the most valuable public company. Nike — The athletic clothing maker moved 1% higher following an upgrade at Oppenheimer to outperform from market perform. Asana — Shares popped more than 3% after the software firm announced a $150 million share buyback plan. Gilead Sciences — The pharmaceutical stock rose more than 2.6%, building on a rally of 8.5% from the previous session. Delta Air Lines — The stock rose 0.7% following news Thursday that the airliner announced a quarterly dividend of 15 cents a share, a 50% increase from previous levels.
Persons: Oppenheimer, Gilead, LendingTree, Bernstein, Toni Sacconaghi, — CNBC's Brian Evans, Michelle Fox, Jesse Pound, Sarah Min Organizations: Nvidia, Microsoft, Sarepta Therapeutics, U.S . Food, Drug Administration, Nike, Gilead Sciences, Bloomberg, Apple —, Air Lines Locations: U.S, Gilead
☆ Stocks making the biggest moves midday: Sarepta Therapeutics, Hertz Global, Asana and more
  + stars: | 2024-06-21 | by ( Sean Conlon | ) www.cnbc.com   time to read: +2 min
Hertz Global — Shares rose more than 10% after the car rental giant upsized a bond offering to $1 billion . Asana — The stock popped 10.5% after the software firm announced a share buyback plan that would cost $150 million. Nvidia — The chipmaker dropped another 1% following a 3.5% decline in the previous session. Gilead Sciences — Shares of the pharmaceutical company popped around 2%, adding to an 8.5% rally from the previous session. Palo Alto Networks — Shares rose 2.4% after D.A.
Persons: Gilead, LendingTree, Davidson, D.A, Boyd Gaming, Boyd, —, Alex Harring, Yun Li, Lisa Kailai Han, Hakyung Kim, Michelle Fox Organizations: Therapeutics, U.S . Food, Drug Administration, FDA, Hertz, Nvidia, Gilead Sciences, Bloomberg, Palo Alto, D.A, Penn Entertainment, Boyd, Reuters, Boeing Locations: U.S, Gilead, Palo, cybersecurity, Thursday's
☆ Stocks making the biggest moves midday: Gilead Sciences, Accenture, Trump Media, AMD and more
  + stars: | 2024-06-20 | by ( Michelle Fox | ) www.cnbc.com   time to read: +3 min
Trump Media & Technology Group — After former President Donald Trump's company said on Tuesday that the Securities and Exchange Commission had declared effective Trump Media's registration of additional shares, the stock dropped 13.5%. Super Micro Computer — Shares jumped 5% after Elon Musk said the company will help his AI firm, xAI, build a supercomputer . Winnebago reported $1.13 in adjusted earnings per share on $786 million of revenue for its fiscal third quarter. Commercial Metals — Shares gained 5.6% after the company reported a revenue beat for its third quarter. Analysts surveyed by LSEG had forecasted $1.80 earnings per share and $1.65 billion in revenue.
Persons: lenacapavir, Donald Trump's, Elon Musk, Piper Sandler, Winnebago, FactSet, Heather Balsky, Jabil, LSEG, —, Alex Harring, Hakyung Kim, Sarah Min, Jesse Pound, Lisa Han Organizations: Accenture, Gilead Sciences, Trump Media & Technology, Securities and Exchange Commission, Trump, Darden, Garden, LongHorn, LSEG . Revenue, Winnebago Industries, Bank of America, Jazz Pharmaceuticals, Metals, Revenue, KB
☆ This little-known biotech stock is primed to surge nearly 50%, Canaccord says
  + stars: | 2024-06-20 | by ( Lisa Kailai Han | ) www.cnbc.com   time to read: +1 min
Positive data from Intra-Cellular Therapies ' latest study could herald further success for the biotechnology stock, according to Canaccord Genuity. The updated forecast implies that shares of Intra-Cellular Therapies could soar nearly 50% from their Tuesday close at $75.48. "We believe the solidity of the Phase 3 data means an approval for luma in MDD is more of a when, not if." Shares of Intra-Cellular Therapies have risen less than 4% this year. But the analyst believes the stock has been "somewhat constrained" due to investors' overly cautious nature with luma's potential patent runway, he wrote.
Persons: Canaccord, Sumant Kulkarni, Kulkarni, —, Fred Imbert Organizations: Therapies, Cellular Locations: MDD
☆ We're trimming an AI winner and putting some of the proceeds into a data center power play
  + stars: | 2024-06-18 | by ( Jeff Marks | ) www.cnbc.com   time to read: +3 min
Shortly after the opening bell, we'll be selling 10 shares of Broadcom at roughly $1,853 and buying 55 shares of Dover at roughly $179. AVGO YTD mountain Broadcom YTD Adding to the enthusiasm was the announcement of a 10-for-1 forward stock split, which came on the heels of one from our other chip name Nvidia . DOV YTD mountain Dover YTD We'll put more than half of the Broadcom sale proceeds to scale further into Dover, which also benefits from the data center infrastructure investment cycle. That data center energy play is also why we're in electrical component and power management giant Eaton . As a subscriber to the CNBC Investing Club with Jim Cramer, you will receive a trade alert before Jim makes a trade.
Persons: Jim Cramer's, DOV, DOV YTD, We'll, Nvidia's Blackwell, ETN DOV, Jim Cramer, Jim Organizations: Broadcom, Dover, VMware, Nvidia, Products Company, CNBC Locations: Dover, Eaton
☆ Alphabet's new CFO was in the middle of the GLP-1 boom. Now she's onto generative AI
  + stars: | 2024-06-06 | by ( Jennifer Elias | ) www.cnbc.com   time to read: +10 min
Alphabet announced on Wednesday that Eli Lilly Chief Financial Officer Anat Ashkenazi will be its new CFO after an almost year-long search. Shares of Eli Lilly have soared 90% in the past year and are trading at a record. When she joined Eli Lilly in 2001, she came in through the company's new venture capital division, which was co-founded by her then-spouse Ron Laufer. Fastest growth in decadesFounded in 1876, Eli Lilly has long been one of the major U.S. pharmaceutical companies. But the last couple years have marked a period of historic growth for Eli Lilly due to the exploding popularity of GLP-1s.
Persons: Anat Ashkenazi, Eli Lilly Eli Lilly Alphabet's, Ruth Porat, Eli Lilly, Ashkenazi, it's, Eli Lilly's, David Ricks, Morgan Stanley, Sundar Pichai, Hollie Adams, Ron Laufer, John Smiley, Eli, It's, Trump, Eli Lilly's Covid, we're, Askhenazi, OpenAI's, Larry Page, Sergey Brin, CNBC's Eric Rosenbaum, Toby Lyles Organizations: San, San Francisco Bay Area, Google, Economic, Bloomberg, Getty, CNBC, Tel Aviv University, Hebrew University, U.S . Food, Drug, U.S . Department of Justice, FDA, Reuters, Employees, NBC Locations: U.S, Indiana, San Francisco Bay, Davos, Switzerland, Israel, biopharma, North Carolina, Germany, New Jersey
☆ Stocks making the biggest moves before the bell: Robinhood, Nvidia, Lululemon, Five Below and more
  + stars: | 2024-06-06 | by ( Alex Harring | ) www.cnbc.com   time to read: +4 min
Five Below told investors to expect between $830 million and $850 million, while analysts polled by LSEG forecasted $883 million. Sprinklr — The business technology stock dove 21.1% in the wake of weak guidance for the current quarter and full year. StoneCo — The financial technology stock rose 2.6% following an upgrade to overweight from neutral by JPMorgan . Ultragenyx Pharmaceutical — The biopharma stock added nearly 4% following an upgrade to buy from neutral at Goldman Sachs. Shopify — The e-commerce technology stock slipped 1.6% on the back of a MoffettNathanson downgrade to neutral from buy.
Persons: Goldman Sachs, Smartsheet, LSEG, Sprinklr, Mizuho, there's, StoneCo, CH Robinson, Goldman, ISI's, Shopify, Guggenheim, —, Jesse Pound, Michelle Fox, Lisa Kailai Han Organizations: Nvidia, LSEG, Revenue, Mizuho, JPMorgan, Ultragenyx Pharmaceutical, Goldman, eBay, Citi, UBS, BMO Capital, BMO, Viridian Therapeutics, ISI, Energy Locations: Americas
☆ Here are Thursday's biggest analyst calls: Apple, Nvidia, Tesla, Netflix, Alphabet, United, JPMorgan, Carvana, Broadcom & more
  + stars: | 2024-06-06 | by ( Michael Bloom | ) www.cnbc.com   time to read: +8 min
Goldman Sachs reiterates Nvidia as buy Goldman said it's sticking with its buy rating on the stock. JPMorgan upgrades StoneCo to overweight from neutral JPMorgan said in its upgrade of the fintech solutions company that it has "appealing" potential for earnings growth. Morgan Stanley reiterates JPMorgan as overweight Morgan Stanley said it's even more bullish on the stock after a meeting with company management. " JPMorgan reiterates Alphabet as overweight JPMorgan said the company is on the "offensive in Gen AI." JPMorgan reiterates Broadcom as overweight The firm said it's sticking with its overweight rating on shares of Broadcom.
Persons: Morgan Stanley, Tesla, Oppenheimer, DA Davidson, Davidson, Goldman Sachs, Goldman, Bernstein, FANG, Redburn, it's bullish, osteogenesis, it's, Robinson, JPMorgan, Disney, Evercore, Moffett, Carvana Organizations: Walmart, Apple, company's, Conference, Nvidia, Energy, Midland shaleco, Endeavor Energy Resources, Airlines, United, Citi, eBay, JPMorgan, BMO, UBS, Mizuho, SEE, P Containers, Deutsche Bank, Deutsche, Google, Jefferies, DFS, Disney, Netflix, CTV, Broadcom Locations: China, Midland, Rocklin
☆ Stocks making the biggest moves midday: Five Below, Salesforce, Lululemon, Instacart and more
  + stars: | 2024-06-06 | by ( Sean Conlon | ) www.cnbc.com   time to read: +3 min
For the current quarter, Five Below said it expects between $830 million and $850 million in revenue, while analysts polled by LSEG expected $883 million. The move was made earlier this week and comes just days after the company reported its first revenue miss since 2006. Lululemon issued weak guidance for the current quarter, but its full-year earnings per share guidance was above expectations. The company recorded earnings of $2.66 per share, which is better than the LSEG consensus estimate of $2.33 in earnings per share. The bank cited its earnings per share potential and discounted valuation as reasons for the call.
Persons: LSEG, ValueAct, Mason Morfit, Lululemon, Sprinklr, Smartsheet, Smucker, Goldman Sachs, —, Samantha Subin, Michelle Fox, Lisa Han, Alex Harring Organizations: LSEG, Revenue, Old Dominion, Fluence Energy, Guggenheim, Ultragenyx Pharmaceutical, JPMorgan
☆ Stocks making the biggest moves premarket: GameStop, Stericycle, MarineMax, Paramount and more
  + stars: | 2024-06-03 | by ( Pia Singh | ) www.cnbc.com   time to read: +3 min
Waste Management , SteriCycle — Shares of medical waste-disposal company Stericycle jumped 16% after Waste Management agreed to buy the company for $7.2 billion. Waste Management fell 1.5%. MarineMax — MarineMax, a recreational boat and yacht services company, popped 19% on a report that OneWater Marine is in talks to buy the company for $40 a share in cash. Boston Beer Company — Shares slid 11% after Bloomberg reported that Japanese brewer and distiller Suntory denied it's in talks to buy the Samuel Adams owner. Paramount Global — Shares added more than 6% after Skydance Media revised its buyout offer for Paramount and gave nonvoting shareholders an option to cash out Paramount Class B shares at a roughly 26% premium to Friday's close.
Persons: Keith Gill, Kitty, Stericycle, —, Cava, Rubin, Blackwell, it's, Samuel Adams, Alex Harring, Brian Evans, Michelle Fox Theobald Organizations: GameStop, AMC Entertainment, AMC, Waste Management, Bloomberg, JPMorgan, Nvidia, AMD, Monday, Sunday, Bank of America, Boston Beer, Suntory, Street, Citi, Spotify, GSK, Autodesk — Autodesk, Paramount, Skydance Media Locations: Cava, Taipei, U.S, Delaware
☆ We're buying more of our newest position and a health-care stock we have battled
  + stars: | 2024-05-29 | by ( Jeff Marks | ) www.cnbc.com   time to read: +4 min
We are buying 75 shares of Dover at roughly $181.64 and 75 shares of GE Healthcare at roughly $78.31. We're also nibbling on more GE Healthcare. We also bought GE Healthcare on May 8. As a subscriber to the CNBC Investing Club with Jim Cramer, you will receive a trade alert before Jim makes a trade. Jim waits 45 minutes after sending a trade alert before buying or selling a stock in his charitable trust's portfolio.
Persons: Jim Cramer's, DOV, We're, Jay Saccaro, GEHC, Jim Cramer, Jim Organizations: Dover, GE Healthcare, GEHC, Club, Systems, GE, CNBC, Midland Manufacturing Locations: Dover, China
☆ Stocks making the biggest moves midday: GameStop, U.S. Cellular, Nvidia, Norwegian Cruise Line and more
  + stars: | 2024-05-28 | by ( Michelle Fox | ) www.cnbc.com   time to read: +4 min
Check out the companies making the biggest moves midday: GameStop — Shares jumped nearly 23% following the video game retailer's announcement on Friday that it made about $933 million from a stock sale. U.S. Cellular — Shares added 7% after the telecom company announced T-Mobile will acquire its wireless operations and 30% of spectrum assets for $4.4 billion. T-Mobile was up less than 1%, while Telephone and Data Systems , which owns 84% of U.S. Cellular, slipped 2%. Norwegian Cruise Line — The cruise stock rose 3% after an upgrade to buy from neutral at Mizuho. Zscaler — The cybersecurity company shed nearly 4% following a downgrade at Wells Fargo to equal weight from overweight.
Persons: Agios, vorasidenib, —, Duolingo Max, Semler, Elon, Zscaler, Airbnb, Eli Lilly, Macheel, Pia Singh, Hakyung Kim, Jesse Pound Organizations: GameStop, . Illinois, U.S, Cellular, Mobile, Telephone, Data Systems, U.S . Cellular, . Food, Drug, Pharmaceuticals, Royalty Pharma, Nvidia, Cruise, Mizuho, Sarepta Therapeutics, RBC Capital Markets, RBC, Sea, Reuters, —, Energy Capital Partners, Wedbush, FDA Locations: U.S, Norwegian, Wells
☆ We're initiating a position in a turnaround stock and buying more of another name
  + stars: | 2024-05-28 | by ( Jeff Marks | ) www.cnbc.com   time to read: +8 min
Shortly after the opening bell, we will initiate a position in Dover by buying 100 shares at roughly $184.20. Meanwhile, total revenue was up 1% — the first positive growth since the first quarter of last year — to $2.09 billion, ahead of the expected $2.03 billion. That business posted 9.2% organic growth and total revenues of $543 million, far above the expected $495 million. Another standout business was pumps and process solutions, which had 4.5% organic growth and total revenue of $466 million, beating the expected $441 million consensus estimate. Jim waits 45 minutes after sending a trade alert before buying or selling a stock in his charitable trust's portfolio.
Persons: Jim Cramer's, DOV, We'll, Jim Cramer, Jim Organizations: DuPont, Dupont, Management, Dover, Citi, CNBC Locations: Dover
☆ This up-and-coming cancer treatment could be a $25 billion market opportunity — it's already a hotbed for M&A
  + stars: | 2024-05-23 | by ( Michelle Fox | ) www.cnbc.com   time to read: +7 min
RBC Capital Markets sees a $25 billion market opportunity for the space. The average analyst rating is hold, with 8% upside to the average analyst price target, according to FactSet. Eli Lilly has an average analyst rating of overweight and 8.3% upside to the average analyst price target, according to FactSet. Stock Chart Icon Stock chart icon AstraZeneca's one-year performanceAstraZeneca shares have an average analyst rating of overweight and nearly 6% upside to the average analyst price target, according to FactSet. Stock Chart Icon Stock chart icon Bristol-Myers Squibb's one-year performance
Persons: It's, Gregory Renza, Renza, Oppenheimer, Jeff Jones, Piper Sandler, Edward Tenthoff, Eli Lilly, Dan Lyons, Janus Henderson, Myers Squibb, William Blair, Matt Phipps, Jefferies, Andrew Tsai, They've, Janus Henderson's Lyons, Jones, Piper Sandler's Tenthoff, Myers Organizations: pharma, RBC Capital Markets, TRT, Novartis, Mariana Oncology, Janus, Janus Henderson Investors, Bristol, RayzeBio, Karuna Therapeutics, AstraZeneca, Fusion Pharmaceuticals, GlobalData's Pharma Intelligence, Pluvicto Locations: Mariana, Bristol
☆ A corner of the cancer therapy market is heating up—Here are the names investors need to know
  + stars: | 2024-05-23 | by ( Michelle Fox | ) www.cnbc.com   time to read: +8 min
A $25 billion market Meanwhile, RBC Capital Markets sees a $25 billion market opportunity for the space. A name Jones likes is Perspective Therapeutics , which he rates outperform. CATX 1Y mountain Perspective Therapeutics year to date Cantor Fitzgerald is also bullish on the name. So it's really an ideal profile," said Piper Sandler analyst Edward Tenthoff, who doesn't cover Perspective Therapeutics. Then there is Lantheus Holdings , which calls itself a radiopharmaceutical-focused company and has a $5.6 billion market cap.
Persons: There's, Eli Lilly, Myers, Jefferies, Andrew Tsai, radiopharma, Oppenheimer, Jeff Jones, FactSet, William Blair, Read, — it's, Andy Hsieh, Gregory Renza, Jones, Cantor Fitzgerald, Louise Chen, it's, Piper Sandler, Edward Tenthoff, Dan Lyons, Janus Henderson, Lantheus, Roanna Ruiz Organizations: Novartis, pharma, Mariana Oncology, Myers Squibb, AstraZeneca, Fusion Pharmaceuticals, RBC Capital Markets, TRT, Therapeutics, Alpha, Janus, Janus Henderson Investors, Lantheus Holdings, Lantheus, Leerink, ~$ Locations: Biopharma, Bristol, Mariana, radiopharma, New Jersey
☆ This overlooked obesity-drug stock has 80% upside, JPMorgan says
  + stars: | 2024-05-21 | by ( Matthew Fox | ) www.businessinsider.com   time to read: +3 min
Structure Therapeutics is an overlooked stock that could surge on the GLP-1 weight loss craze. "Meaningful upside from even a small piece of unprecedentedly large GLP-1 market," JPMorgan said. AdvertisementStructure Therapeutics is developing the drug candidate dubbed "1290," which is a "pure-play option" for the GLP-1 weight loss market, according to JPMorgan. JPMorgan said early results suggest the drug candidate offers "on par" weight loss results for patients with "no major concerns on safety." Advertisement"We think GPCR's market share in the oral market can approach 5% over time in an unprecedentedly large market.
Persons: —, Eli Lilly, Eli, orforglipron, Eli Lilly's Organizations: Therapeutics, JPMorgan, Service, Novo Nordisk, GLPP, Nasdaq
☆ Here are Friday's biggest analyst calls: Nvidia, Tesla, Robinhood, Salesforce, Netflix, Roblox, Chevron, Walmart & more
  + stars: | 2024-05-17 | by ( Michael Bloom | ) www.cnbc.com   time to read: +7 min
Here are Friday's biggest calls on Wall Street: Bank of America reiterates Nvidia as buy Bank of America said top pick Nvidia remains "compelling" heading into earnings next week. Bank of America reiterates Marvell as buy Bank of America said it's sticking with its buy rating heading into earnings later this month. " Citi reiterates Walmart as a top pick Citi said the stock remains a top pick following earnings. Chevron Corp. (CVX): Reiterate Constructive View on Inflecting FCF Generation and Relative Valuation; Buy with 13% Total Return." "Near-term caution is offset by our increasingly bullish medium-term outlook, where CRM is well positioned for GenAI & valuation remains undemanding."
Persons: Marvell, Roth, Ree, Roth MKM, it's, REE, Wells, Oppenheimer, Reddit, Goldman Sachs, Tesla, Goldman, BTIG, Baird, Jefferies, Morgan Stanley, Baidu, Wolfe, UAL, Cantor Fitzgerald, Cantor, Price, Stifel, Salesforce Organizations: Bank of America, Nvidia, Ree Automotive, EV, Netflix, Citi, OpenAI, Google, Walmart, Darden, Jefferies, DuPont, Macquarie, Stock, underperform Bank of America, Chevron, Chevron Corp, JPMorgan, Body, United Airlines, Price Target, Health, Base Locations: Thu, Olive, China, United, Underperform
☆ Here are Tuesday's biggest analyst calls: Apple, Nvidia, Amazon, Tesla, Seagate, Boston Beer, Planet Fitness & more
  + stars: | 2024-05-14 | by ( Michael Bloom | ) www.cnbc.com   time to read: +6 min
Wells Fargo reiterates Nvidia as overweight Wells increased its price target on Nvidia to $1,150 per share from $970. Jefferies upgrades Boston Beer to buy from hold Jefferies said in its upgrade of the beverage company that it sees "multiple expansion." Bank of America reiterates Apple as buy Bank of America said it's sticking with its buy rating on shares of Apple. JPMorgan upgrades Planet Fitness to overweight from neutral JPMorgan said in its has increased confidence in Planet Fitness' growth. JPMorgan upgrades Vtex to overweight from neutral JPMorgan said it sees an attractive entry point for the software-as-a-service company.
Persons: Tesla, Goldman Sachs, Goldman, it's, Wells, ests, Jefferies, Beer, Roth, Morgan Stanley, GXO's, Baird, Oppenheimer, Edwards Organizations: Barclays, Oncology, Fulcrum Therapeutics, ISI, Nvidia, Jefferies, Boston Beer, GXO Logistics, Bank of America, Apple, HSBC, Citi, Weatherford, Energy, JPMorgan, LT, Fortrea Holdings, Edison International, RBC, North, Deutsche Bank, Amazon, Deutsche, Western Digital, Seagate Locations: China, North America
<< prev 1 next >>
Total: 25